Literature DB >> 21640497

Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.

Benjamin H Lok1, Jeremy Setton, Nicola Caria, Jonathan Romanyshyn, Suzanne L Wolden, Michael J Zelefsky, Jeffery Park, Nicholas Rowan, Eric J Sherman, Matthew G Fury, Alan Ho, David G Pfister, Richard J Wong, Jatin P Shah, Dennis H Kraus, Zhigang Zhang, Karen D Schupak, Daphna Y Gelblum, Shyam D Rao, Nancy Y Lee.   

Abstract

PURPOSE: To analyze the effect of primary gross tumor volume (pGTV) and nodal gross tumor volume (nGTV) on treatment outcomes in patients treated with definitive intensity-modulated radiation therapy (IMRT) for oropharyngeal cancer (OPC). METHODS AND MATERIALS: Between September 1998 and April 2009, a total of 442 patients with squamous cell carcinoma of the oropharynx were treated with IMRT with curative intent at our center. Thirty patients treated postoperatively and 2 additional patients who started treatment more than 6 months after diagnosis were excluded. A total of 340 patients with restorable treatment plans were included in this present study. The majority of the patients underwent concurrent platinum-based chemotherapy. The pGTV and nGTV were calculated using the original clinical treatment plans. Cox proportional hazards models and log-rank tests were used to evaluate the correlation between tumor volumes and overall survival (OS), and competing risks analysis tools were used to evaluate the correlation between local failure (LF), regional failure (RF), distant metastatic failure (DMF) vs. tumor volumes with death as a competing risk.
RESULTS: Median follow-up among surviving patients was 34 months (range, 5-67). The 2-year cumulative incidence of LF, RF and DF in this cohort of patients was 6.1%, 5.2%, and 12.2%, respectively. The 2-year OS rate was 88.6%. Univariate analysis determined pGTV and T-stage correlated with LF (p < 0.0001 and p = 0.004, respectively), whereas nGTV was not associated with RF. On multivariate analysis, pGTV and N-stage were independent risk factors for overall survival (p = 0.0003 and p = 0.0073, respectively) and distant control (p = 0.0008 and p = 0.002, respectively).
CONCLUSIONS: In this cohort of patients with OPC treated with IMRT, pGTV was found to be associated with overall survival, local failure, and distant metastatic failure. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640497      PMCID: PMC4978948          DOI: 10.1016/j.ijrobp.2011.03.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

1.  Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy.

Authors:  F A Pameijer; A A Mancuso; W M Mendenhall; J T Parsons; S K Mukherji; R Hermans; P S Kubilis
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

2.  The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy.

Authors:  R M Nathu; A A Mancuso; T C Zhu; W M Mendenhall
Journal:  Head Neck       Date:  2000-01       Impact factor: 3.147

3.  The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment.

Authors:  R Hermans; K Op de beeck; W Van den Bogaert; A Rijnders; L Staelens; M Feron; E Bellon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-05-01       Impact factor: 7.038

4.  Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

Authors:  Fernando F de Arruda; Dev R Puri; Joanne Zhung; Ashwatha Narayana; Suzanne Wolden; Margie Hunt; Hilda Stambuk; David Pfister; Dennis Kraus; Ashok Shaha; Jatin Shah; Nancy Y Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-05-31       Impact factor: 7.038

5.  Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma.

Authors:  J R Kraas; T E Underhill; R B D'Agostino; D W Williams; J A Cox; K M Greven
Journal:  Head Neck       Date:  2001-12       Impact factor: 3.147

6.  Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival.

Authors:  H Mellin; S Friesland; R Lewensohn; T Dalianis; E Munck-Wikland
Journal:  Int J Cancer       Date:  2000-05-20       Impact factor: 7.396

7.  Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome.

Authors:  D T Chua; J S Sham; D L Kwong; K S Tai; P M Wu; M Lo; A Yung; D Choy; L Leong
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

8.  Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.

Authors:  K S Clifford Chao; Gokhan Ozyigit; Angel I Blanco; Wade L Thorstad; Joseph O Deasy; Bruce H Haughey; Gershon J Spector; Donald G Sessions
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

9.  Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.

Authors:  Mark J Been; Joanna Watkins; Ryan M Manz; Lindell R Gentry; Glen E Leverson; Paul M Harari; Gregory K Hartig
Journal:  Laryngoscope       Date:  2008-08       Impact factor: 3.325

10.  Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck.

Authors:  William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; Anthony A Mancuso
Journal:  Head Neck       Date:  2003-07       Impact factor: 3.147

View more
  28 in total

1.  The effect of slice thickness on target and organs at risk volumes, dosimetric coverage and radiobiological impact in IMRT planning.

Authors:  S P Srivastava; C-W Cheng; I J Das
Journal:  Clin Transl Oncol       Date:  2015-08-27       Impact factor: 3.405

2.  Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Jonathan B McHugh; Ka Kit Wong; Heather M Walline; Serena A Byrd; Christine M Komarck; Mohannad Ibrahim; Matthew H Stenmark; Mark E Prince; Carol R Bradford; Gregory T Wolf; Scott McLean; Francis P Worden; Douglas B Chepeha; Thomas Carey; Avraham Eisbruch
Journal:  Oral Oncol       Date:  2014-02-22       Impact factor: 5.337

3.  The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan.

Authors:  Paul B Romesser; Remy Lim; Daniel E Spratt; Jeremy Setton; Nadeem Riaz; Benjamin Lok; Shyam Rao; Eric J Sherman; Heiko Schöder; Nancy Y Lee
Journal:  Oral Oncol       Date:  2014-07-17       Impact factor: 5.337

4.  Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models.

Authors:  Adam D Yock; Arvind Rao; Lei Dong; Beth M Beadle; Adam S Garden; Rajat J Kudchadker; Laurence E Court
Journal:  Med Phys       Date:  2014-05       Impact factor: 4.071

5.  FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.

Authors:  Abdel K Tahari; Krishna C Alluri; Harry Quon; Wayne Koch; Richard L Wahl; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2014-03       Impact factor: 7.794

6.  Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer.

Authors:  Kara S Davis; Chwee Ming Lim; David A Clump; Dwight E Heron; James P Ohr; Seungwon Kim; Umamaheswar Duvvuri; Jonas T Johnson; Robert L Ferris
Journal:  Head Neck       Date:  2015-12-17       Impact factor: 3.147

7.  0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers.

Authors:  N-T A Nguyen; L Doerwald-Munoz; H Zhang; D-H Kim; S Sagar; J R Wright; D I Hodson
Journal:  Br J Radiol       Date:  2015-02-19       Impact factor: 3.039

8.  Prognostic value of tumor volumetry data of routine imaging data in a head and neck cancer registry.

Authors:  Daniela Oemus; Johanna Inhestern; Harald Schmalenberg; Stefan Schultze-Mosgau; Hans-Joachim Mentzel; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-06       Impact factor: 2.503

9.  A prognostic volumetric threshold of gross tumor volume in head and neck cancer patients treated with radiotherapy.

Authors:  Paul B Romesser; Muhammad M Qureshi; Rathan M Subramaniam; Osamu Sakai; Scharukh Jalisi; Minh T Truong
Journal:  Am J Clin Oncol       Date:  2014-04       Impact factor: 2.339

10.  Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.

Authors:  Timo Carpén; Kauko Saarilahti; Caj Haglund; Antti Markkola; Jussi Tarkkanen; Jaana Hagström; Petri Mattila; Antti Mäkitie
Journal:  Strahlenther Onkol       Date:  2018-05-17       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.